-
Signature
-
/s/ Nick Pizzie, Attorney-in-Fact
-
Issuer symbol
-
AXSM
-
Transactions as of
-
31 Dec 2025
-
Net transactions value
-
-$6,001,834
-
Form type
-
4
-
Filing time
-
02 Jan 2026, 19:02:02 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Saad Mark E |
Director |
C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK |
/s/ Nick Pizzie, Attorney-in-Fact |
02 Jan 2026 |
0001295913 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AXSM |
Common Stock |
Options Exercise |
$49,973 |
+6,231 |
+62% |
$8.02 |
16,233 |
31 Dec 2025 |
Direct |
F1, F2 |
| transaction |
AXSM |
Common Stock |
Sale |
$1,029,237 |
-6,231 |
-38% |
$165.18 |
10,002 |
31 Dec 2025 |
Direct |
F2, F3, F4 |
| transaction |
AXSM |
Common Stock |
Options Exercise |
$155,163 |
+31,346 |
+313% |
$4.95 |
41,348 |
31 Dec 2025 |
Direct |
F1, F2 |
| transaction |
AXSM |
Common Stock |
Sale |
$5,177,732 |
-31,346 |
-76% |
$165.18 |
10,002 |
31 Dec 2025 |
Direct |
F2, F3, F4 |
| holding |
AXSM |
Common Stock |
|
|
|
|
|
300 |
31 Dec 2025 |
See explanation 5 below. |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AXSM |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-6,231 |
-100% |
$0.000000 |
0 |
31 Dec 2025 |
Common Stock |
6,231 |
$8.02 |
Direct |
F1, F2 |
| transaction |
AXSM |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-31,346 |
-100% |
$0.000000 |
0 |
31 Dec 2025 |
Common Stock |
31,346 |
$4.95 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: